Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer

NCT01987232

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • UF Health Davis Cancer Pavilion and Shands Med Plaza Gainesville, Florida, United States
  • Goshen Center for Cancer Care Goshen, Indiana, United States
  • Horizon Oncology Research, Inc. Lafayette, Indiana, United States
View all 17 locations
View Trial Details
Completed

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00828139

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +9 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Arizona Cancer Center at UMC Orange Grove Tucson, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
View all 257 locations
View Trial Details
Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions
Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

NCT02010047

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • BC Cancer Agency-Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer Agency-Centre for the Southern Interior Kelowna, British Columbia, Canada
  • Lions Gate Hospital North Vancouver, British Columbia, Canada
  • BC Cancer Agency-Centre for the North Prince George, British Columbia, Canada
View Trial Details

Related conditions